A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Clinical trial NCT03104374 · COMPLETED
Trial details
- NCT number
- NCT03104374
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2019-07-23
- Enrollment
- 642
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.